Test Price
2,800 AED✅ Home Collection Available
POU3F4 Gene X‑Linked Deafness Type 2 Genetic Test in UAE – 2800 AED – DHA Licensed
Executive Summary & Core Metrics
Executive Summary
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity through ISO 9001:2015 Certified Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation provided by DHA-licensed physicians.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731 (PDPL-compliant).
Test Overview & Methodology
This NGS‑based genetic test screens for pathogenic variants in the POU3F4 gene, the primary cause of X‑linked deafness type 2 (DFNX2), enabling early diagnosis, family risk assessment, and personalised management. The test analyses the entire coding region and exon‑intron boundaries using Next‑Generation Sequencing to detect single nucleotide variants, deletions, and duplications. The condition primarily affects males, while female carriers may show mild or progressive hearing loss.
| Features | Our POU3F4 NGS Test | Common Single‑Gene Sanger Sequencing |
|---|---|---|
| Precision | >99.9% Analytical Sensitivity & Specificity (ISO‑accredited) | ~99% sensitivity for single variant, misses entire gene coverage |
| Methodology | Next‑Generation Sequencing (NGS) with full gene sequencing & copy number analysis | Targeted Sanger for known hotspot variants only |
| Speed | 3 to 4 Weeks (Cold‑Chain Home Collection included) | 4 to 8 Weeks (often outsourced) |
| UAE Compliance | DHA guidelines, Federal Decree‑Law No. 45 of 2021 (PDPL), Federal Law No. 2 of 2019, Federal Decree‑Law No. 4 of 2016 | Often not explicitly compliant |
Physician Insight & Safety Protocols
“Hearing is a gift. Genetic testing for POU3F4 variants gives families clarity, but every result must be interpreted alongside comprehensive audiometric evaluation and family history. I urge you to never skip genetic counselling – it transforms data into actionable health decisions.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
⚠️ Important Clinical Advisory
Do not discontinue any prescribed medication without consulting your treating physician. This genetic test does not diagnose current active ear disease; it identifies hereditary risk. Always combine results with clinical evaluation.
Exclusion Criteria & Emergency Red Flags
- Acute onset of sensorineural hearing loss cannot be evaluated solely by this test.
- Contraindicated for patients with active ear infection or recent craniofacial trauma until stabilised.
- ER red flags: sudden hearing loss with vertigo, severe tinnitus, or facial asymmetry – seek immediate ENT care; this test is not for acute diagnostics.
Patient FAQ & Clinical Guidance
1. What is the POU3F4 gene test for?
Snippet: This test identifies pathogenic variants in the POU3F4 gene responsible for X-linked deafness type 2 (DFNX2).
It analyses the entire coding region and exon-intron boundaries using Next-Generation Sequencing to detect single nucleotide variants, deletions, and duplications. The condition primarily affects males, while female carriers may show mild or progressive hearing loss.
2. How accurate is the test, and is it approved by DHA?
Snippet: Our ISO-accredited NGS achieves >99.9% analytical sensitivity, fully aligned with DHA molecular diagnostic standards.
The laboratory holds ISO 9001:2015 certification (INT/EGQ/2509DA/3139) and operates under Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All reporting is compliant with UAE PDPL data privacy, ensuring ethical handling of genetic data.
3. How do I prepare for the test and what’s the turnaround time?
Snippet: A simple blood draw or one drop of blood on an FTA card is collected at home; results arrive in 3–4 weeks.
No fasting required. Pre‑genetic counselling is mandatory (included) to construct a detailed family pedigree and explain potential outcomes. Our VIP mobile phlebotomy team visits between 8 AM and 11 PM from Monday to Saturday. You will receive a telephonic interpretation session with a DHA-licensed genetic counsellor.
UAE Regulatory & Data Privacy Adherence
Trust & Compliance Framework
All genetic testing operations are conducted under the strict oversight of the Dubai Health Authority (DHA) and fully comply with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and consent protocols adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. Our laboratory is ISO 9001:2015 certified, and all genetic data is encrypted and stored within the UAE.
Clinical & Logistical Metadata
| Test Name | POU3F4 Gene X‑Linked Deafness Type 2 Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 to 4 weeks |
| Sample Type / Matrix | Peripheral whole blood or dried blood spot (FTA card) |
| Methodology Used | Next‑Generation Sequencing (NGS) with full gene sequencing & copy number analysis |
| ICD-10-CM Code | H90.3 (Bilateral sensorineural hearing loss) |
| LOINC Code | 92432-6 (POU3F4 gene mutation analysis) |
| DHA Facility License & Laboratory Address | License: 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians